Valneva SE (VALN) Return on Invested Capital (2022 - 2026)
Valneva SE's (VALN) quarterly Return on Invested Capital came in at 0.01% in Q1 2026, little changed year-on-year from 0.01% in Q1 2025, and down 19.41% quarter-over-quarter from 0.0% in Q4 2025.
Valneva SE (VALN) Return on Invested Capital (2022 - 2026) Analysis & Trends
Valneva SE has disclosed Return on Invested Capital across 5 years of filings, most recently posting 0.01% for Q1 2026.
- Return on Invested Capital for Q1 2026 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, down 1.0% from the prior year.
- Return on Invested Capital came in at 0.01% for Q1 2026 at Valneva SE, down from 0.0% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q3 2022 to a low of 0.01% in Q2 2022.
- The 5-year median for Return on Invested Capital is 0.0% (2024), against an average of 0.0%.
- Peak annual rise in Return on Invested Capital reached 0 bps in 2023, while the deepest fall reached 0 bps in 2023.
- Valneva SE's Return on Invested Capital stood at 0.01% in 2022, then climbed by 12 bps to 0.0% in 2023, then soared by 42 bps to 0.0% in 2024, then sank by 70 bps to 0.0% in 2025, then fell by 19 bps to 0.01% in 2026.
- The last three Return on Invested Capital figures came in at 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.01% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -0.01% |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Valneva SE | 167.33 Mn | 44.10 Mn | 5.08 Mn | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.01% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | -0.01% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | 0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |